4.6 Article Proceedings Paper

Evaluation of different add-back estradiol and progesterone treatments to gonadotropin-releasing hormone agonist treatment in patients with premenstrual dysphoric disorder

Journal

Publisher

MOSBY-ELSEVIER
DOI: 10.1016/j.ajog.2009.03.016

Keywords

add-back; estradiol; GnRH agonist; premenstrual dysphoric disorder; progesterone; clinical trial

Ask authors/readers for more resources

OBJECTIVE: The aim of this study was to investigate which add-back hormone replacement therapy would be most beneficial in terms of mood effects for patients with premenstrual dysphoric disorder who are receiving gonadotropin-releasing hormone agonist therapy. STUDY DESIGN: Three different add-back hormone replacement treatments were evaluated in a randomized, double-blinded, cross-over clinical trial in 27 patients premenstrual dysphoric disorder. The add-back treatments consisted of 1.5 mg estradiol and 400 mg progesterone, 1.5 mg estradiol and placebo, and 0.5 mg estradiol and 400 mg progesterone. The primary outcome measure was daily symptom ratings for mood and physical symptoms. RESULTS: The highest dose of estradiol in combination with progesterone was associated with the most pronounced symptom recurrence, both in comparison with a lower dose of estradiol together with progesterone and estradiol-only treatment. CONCLUSION: Based on the findings of the present study, long-cycle add-back treatment to avoid frequent progestagen use appears to be most beneficial for patients with premenstrual dysphoric disorder.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Endocrinology & Metabolism

Positive GABAA receptor modulating steroids and their antagonists: Implications for clinical treatments

Torbjorn Backstrom, Roshni Das, Marie Bixo

Summary: GABA is the main inhibitory neurotransmitter in the brain, and Allopregnanolone (Allo) is a steroid that modulates the GABA(A) receptor, affecting mood, memory, and food intake. While Allo is generally considered to be anxiolytic and anti-depressant, studies have shown that it may have paradoxical effects in certain individuals. A new substance, Isoallopregnanolone (Isoallo), has been discovered to function as a GABA(A) receptor modulating steroid antagonist (GAMSA).

JOURNAL OF NEUROENDOCRINOLOGY (2022)

Article Obstetrics & Gynecology

Gestational weight gain, appetite regulating hormones, and metformin treatment in polycystic ovary syndrome: A longitudinal, placebo-controlled study

Johanna Molin, Eszter Vanky, Tone S. Lovvik, Eva Dehlin, Marie Bixo

Summary: Excessive gestational weight gain (GWG) is associated with enhanced leptin resistance and attenuated physiological increase in serum allopregnanolone levels during pregnancy. Metformin reduces the risk of excessive GWG in pregnant women with PCOS and improves leptin sensitivity.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2022)

Article Public, Environmental & Occupational Health

Prevalence and correlates of current suicidal ideation in women with premenstrual dysphoric disorder

Anna Wikman, Julia Sacher, Marie Bixo, Angelica L. Hirschberg, Helena Kopp Kallner, C. Neill Epperson, Erika Comasco, Inger Sundstrom Poromaa

Summary: Current suicidal ideation was reported by nearly 40% of women with confirmed PMDD in the late luteal phase. Previous psychological treatment for PMDD and higher depressive symptoms in the late luteal phase were positively associated with current suicidal ideation, while higher self-rated health ratings were associated with lower odds ratios for current suicidal ideation.

BMC WOMENS HEALTH (2022)

Article Obstetrics & Gynecology

Long-term outcome after routine surgery for pelvic organ prolapse-A national register-based cohort study

Emil Nussler, Gabriel Granasen, Marie Bixo, Mats Lofgren

Summary: This study investigated the re-operation rates up to 10 years and patient-reported outcomes (PROMs) 5 years after POP surgery. The results showed low re-operation rates and a high response rate in the web-based PROM survey after 5 years. The subjective cure rate after primary POP operations was high, with reduced symptoms and satisfied patients.

INTERNATIONAL UROGYNECOLOGY JOURNAL (2022)

Article Public, Environmental & Occupational Health

Women's decision-making related to induced abortion - a cross sectional study during a period of Covid-19 pandemic, in Sweden

M. Makenzius, C. Obern, T. Tyden, M. Larsson, K. Gemzell-Danielsson, I Sundstrom-Poromaa, M. Ekstrand Ragnar

Summary: This study investigates women's decision-making on induced abortion in Sweden. The results show that half of the women find the decision relatively easy, while the other half finds it difficult. Reasons for choosing abortion include economic difficulties, early stage in the relationship, desire to work or study first, uncertainty about the relationship, and being too young. Factors predicting difficulty in decision-making include partner's hesitance, being born outside the Nordic countries, discussing the decision with someone, age over 30, the Covid-19 pandemic, and the desire to have children in the future.

EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE (2023)

Article Biochemistry & Molecular Biology

Hyperandrogenic Symptoms Are a Persistent Suffering in Midlife Women with PCOS; a Prospective Cohort Study in Sweden

Sofia Persson, Kumari A. Ubhayasekera, Jonas Bergquist, Sahruh Turkmen, Inger Sundstroem Poromaa, Evangelia Elenis

Summary: Polycystic ovary syndrome (PCOS) is a common endocrine disorder among women, and hyperandrogenism can cause psychological morbidity and impaired quality of life. This study aimed to investigate whether hyperandrogenism persists into midlife and its impact on quality of life.

BIOMEDICINES (2023)

Article Obstetrics & Gynecology

Altered GABAA receptor function in women with endometriosis: a possible pain-related mechanism

Anton Sandstrom, Marie Bixo, Torbjoern Backstrom, Anna Moller, Sahruh Turkmen

Summary: A study found that women with painful endometriosis have lower sensitivity to GABA(A) receptor stimulation compared to healthy controls. This indicates altered GABA(A) receptor function in the context of endometriosis-related pain.

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2023)

Article Clinical Neurology

New Pharmacological Approaches to the Management of Premenstrual Dysphoric Disorder

Inger Sundstrom-Poromaa, Erika Comasco

Summary: Premenstrual symptoms are common among women of reproductive age, with 5% experiencing premenstrual dysphoric disorder (PMDD) during the luteal phase. Selective serotonin reuptake inhibitors are effective for many patients, but not all. Recent research shows that treatment with a selective progesterone receptor modulator (SPRM) significantly reduces the severity of PMDD symptoms, with minimal side effects.

CNS DRUGS (2023)

Article Public, Environmental & Occupational Health

Multiple induced abortions - implications for counselling and contraceptive services from a multi-centre cross-sectional study in Sweden

Cerisa Obern, Maria Ekstrand Ragnar, Tanja Tyden, Margareta Larsson, Jenny Niemeyer Hultstrand, Kristina Gemzell-Danielsson, Inger Sundstrom-Poromaa, Marlene Makenzius

Summary: Multiple abortions are common in Sweden and are linked to parity, low education, tobacco use, and exposure to violence. Although Sweden offers high-quality and accessible comprehensive abortion care, counseling should be adaptable and address specific needs in vulnerable groups.

EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE (2023)

Editorial Material Neurosciences

Towards a more comprehensive neuroscience of hormonal contraceptives

Nicole Petersen, Adriene M. Beltz, Kathleen V. Casto, Caitlin M. Taylor, Emily G. Jacobs, Inger Sundstroem-Poromaa, Belinda Pletzer

Summary: The neuroscience of hormonal contraceptives is a crucial yet emerging field. Although limited in size and scope, existing studies emphasize the complex effects of hormonal contraceptives on the nervous system, which can vary due to individual differences, contraceptive type and formulation, and timing of use. Neuroscientists can provide individuals with knowledge about the biopsychological effects of hormonal contraceptives through rigorous randomized controlled trials, large-scale studies examining population-level trends, and dense imaging or intensive longitudinal studies assessing individual-level effects.

NATURE NEUROSCIENCE (2023)

Article Medicine, General & Internal

Study protocol: The cross-sectional Uppsala weight gain in pregnancy study (VIGA study)

Theodora Kunovac Kallak, Alice Zancanaro, Katja Junus, Anna-Karin Wikstroem, Inger Sundstroem Poromaa, Susanne Lager

Summary: This is a cross-sectional study aiming to investigate the associations between maternal weight, diet, exercise, pregnancy weight gain, and pregnancy outcome. Pregnant women at Uppsala University Hospital, Sweden were included in the study. Questionnaires regarding their dietary and exercise habits were collected, along with samples of maternal adipose tissues and placental tissue for analysis. The results will be published in peer-reviewed, international scientific journals.

UPSALA JOURNAL OF MEDICAL SCIENCES (2023)

Article Psychiatry

Emotion-induced brain activation across the menstrual cycle in individuals with premenstrual dysphoric disorder and associations to serum levels of progesterone-derived neurosteroids

Louise Stiernman, Manon Dubol, Erika Comasco, Inger Sundstrom-Poromaa, Carl-Johan Boraxbekk, Maja Johansson, Marie Bixo

Summary: Premenstrual dysphoric disorder (PMDD) is associated with altered sensitivity to ALLO and ISO, neurosteroids that affect GABA(A) activity. ISO has been shown to alleviate PMDD symptoms. In this study, PMDD subjects exhibited increased brain activity during emotion processing in the late-luteal phase. The relationship between ISO/ALLO ratio and brain activity differed between PMDD subjects and controls in key emotion processing regions.

TRANSLATIONAL PSYCHIATRY (2023)

Article Psychiatry

Triple network model of brain connectivity changes related to adverse mood effects in an oral contraceptive placebo-controlled trial

Esmeralda Hidalgo-Lopez, Jonas Engman, Inger Sundstrom Poromaa, Malin Gingnell, Belinda Pletzer

Summary: This study investigated the effects of hormonal contraceptives on mood side effects and found that they caused increased connectivity within the default mode network and decreased connectivity within the executive control network. Mood lability was the most consistent and prominent side effect.

TRANSLATIONAL PSYCHIATRY (2023)

Article Obstetrics & Gynecology

Contraceptive use among women seeking an early induced abortion in Sweden

Jenny Niemeyer Hultstrand, Elin Tornroos, Tanja Tyden, Margareta Larsson, Marlene Makenzius, Kristina Gemzell-Danielsson, Inger Sundstrom-Poromaa, Maria Ekstrand Ragnar

Summary: Despite efforts to promote women's sexual and reproductive health in Sweden, many women seeking abortion still have unmet contraceptive needs. This study investigated the contraceptive use among these women, revealing a high rate of non-use and discontinuation of contraception. Limited fertility awareness and negative experiences with contraceptives were identified as factors contributing to the unmet need.

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2023)

No Data Available